| Autor: |
Adrian L. Harris, Richard Poulsom, Craig P. Montgomery, Angela J. Russell, Partha S. Chowdhury, Herren Wu, Emma T. Bowden, Cameron Snell, Wen Shi, Esther Bridges, Helen Sheldon, Russell Leek, Helen Turley, Chern Ein Oon, Richard C.A. Sainson, Ji-Liang Li |
| Rok vydání: |
2023 |
| DOI: |
10.1158/0008-5472.22388565 |
| Popis: |
PDF file - 740K, Neither anti-EphrinB2 nor sEphB4 affected the growth of U87-EV tumors in vivo. Compared to the control, neutralizing anti-EphrinB2 antibody (B2) alone (blue arrowhead) did not affect the tumor growth. Also, combined anti-EphrinB2 antibody (blue arrowhead) with bevacizumab (purple arrowhead) did not increase the therapeutic efficacy of bevacizumab. Similar results were obtained for sEphB4. Mean � SE, N=5. **P |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
